| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507761 Benzopyran derivatives, method of production and use thereof |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507747 Muscarinic acetylcholine receptor antagonists |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507733 11b-HSD1 inhibitors for the treatment of diabetes |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009035969A1 Process for the preparation of compounds useful as inhibitors of sglt |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2008149379A3 Novel compounds |
| 03/19/2009 | WO2008131946A3 Substituted amide derivatives |
| 03/19/2009 | US20090076254 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators and diagnosis, treatment and prevention of neurodegenerative, psychological, and sleep disorders |
| 03/19/2009 | US20090076103 Stem cell differentiating agents and uses therefor |
| 03/19/2009 | US20090076086 Substituted nicotinamide compounds and uses thereof |
| 03/19/2009 | US20090076077 Methods and Compositions for Selectin Inhibition |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/19/2009 | DE102007044277A1 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln Substituted nicotinamide compounds and their use in medicaments |
| 03/19/2009 | DE102007044032A1 New substituted heteroaryl compounds are hypoxia-inducible factor prolyl-4-hydroxylase inhibitors useful to treat and/or prevent e.g. circulatory heart diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 03/19/2009 | CA2699285A1 Process for the preparation of compounds useful as inhibitors of sglt |
| 03/18/2009 | EP2036898A2 Method for manufacturing 1.3 dioxolane 2ones and carboxylic acid esters by transacylation under alkaline reaction conditions |
| 03/18/2009 | EP2036896A1 Cyclic amine compound |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2035416A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 03/18/2009 | EP2035415A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/18/2009 | EP2035411A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia. |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389608A 5-HT7 receptor antagonists |
| 03/18/2009 | CN100469769C Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 03/17/2009 | US7504522 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/17/2009 | US7504520 8-({5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl}amino)-3,4-dihydronaphthalen-2(1H) one; treating pain, bladder overactivity, and urinary incontinence |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504422 Polyamine compounds |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504362 Pesticidal compositions |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 03/12/2009 | WO2009032326A1 New tetracycline derivatives as antiinfective agents |
| 03/12/2009 | WO2009032277A1 Gamma secretase modulators |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009031643A1 Antifungal composition |
| 03/12/2009 | WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 03/12/2009 | WO2009030819A1 Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof |
| 03/12/2009 | WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/12/2009 | WO2009003672A3 Novel microbiocides |
| 03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
| 03/12/2009 | WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069382 Bicyclic Angiotensin II Agonists |
| 03/12/2009 | US20090069381 Deuterium-enriched raloxifene |
| 03/12/2009 | US20090069380 Deuterium-enriched aroxifene |
| 03/12/2009 | US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/12/2009 | US20090069328 Alpha-alkyl substituted n-acyltryptophanols |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069316 Novel quinoline derivatives |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069301 Acridine and Quinoline Derivatives as Sirtuin Modulators |
| 03/12/2009 | US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/12/2009 | US20090069252 C-glycoside derivatives and salts thereof |
| 03/12/2009 | US20090069250 Inhibitors of Histone Deacetylase |
| 03/12/2009 | US20090067030 transparent electrode, polymer based on fluorinated derivative of (2,3-Di-thiophen-2-yl-thieno[3,4-b]pyrazine), and electrolyte; single absorption band |
| 03/12/2009 | US20090066235 Aromatic amine derivative and organic electroluminescence device using the same |
| 03/12/2009 | CA2698341A1 Gamma secretase modulators |
| 03/12/2009 | CA2696824A1 Compounds and compositions as kinase inhibitors |
| 03/11/2009 | EP2034000A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032564A2 Substituted benzimidazole thiophene benzyl ether compounds |
| 03/11/2009 | EP2032563A2 Benzimidazol substituted thiophene derivatives with activity on plk |
| 03/11/2009 | EP2032562A2 Selective inhibitors of rock protein kinase and uses thereof |
| 03/11/2009 | EP2032542A2 Heterocyclic aspartyl protease inhibitors |
| 03/11/2009 | EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1319659B1 Triazinones and medicinal use thereof |
| 03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
| 03/11/2009 | EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk) |